In my manifesto on Tolvaptan, I mentioned there was another breakthrough that should be on the list of top stories of 2013, and it is…The gathering momentum of renal denervation for hypertension. This feels like it is rapidly maturing and will be a viable option in the near future.
The latest data presented at American Heart Association looks promising.
Go to Renal Fellow Network. Vote for your favorite!